Shandong Sanyuan Biotechnology Co.Ltd. (301206) — Capital Reinvestment Ratio
Shandong Sanyuan Biotechnology Co.Ltd. (301206) has a Capital Reinvestment Ratio of 1.21x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥24.79 Million) in capital expenditures (CN¥29.92 Million). See 301206 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Sanyuan Biotechnology Co.Ltd. Capital Reinvestment Ratio (2013–2023)
This chart tracks Shandong Sanyuan Biotechnology Co.Ltd.'s Capital Reinvestment Ratio across 11 annual periods. Check Shandong Sanyuan Biotechnology Co.Ltd. (301206) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2023)
Year-by-year Capital Reinvestment Ratio for Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2023. For live market cap and broader valuation context, see Shandong Sanyuan Biotechnology Co.Ltd. (301206) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 2.15x | CN¥57.31 Million | CN¥122.99 Million | ▼ -25.5% |
| 2022 | 2.88x | CN¥84.26 Million | CN¥242.67 Million | ▲ +325.7% |
| 2021 | 0.68x | CN¥642.08 Million | CN¥434.37 Million | ▼ -3.1% |
| 2020 | 0.70x | CN¥217.37 Million | CN¥151.76 Million | ▼ -26.0% |
| 2019 | 0.94x | CN¥149.21 Million | CN¥140.73 Million | ▲ +26.9% |
| 2018 | 0.74x | CN¥65.46 Million | CN¥48.65 Million | ▼ -68.2% |
| 2017 | 2.34x | CN¥20.25 Million | CN¥47.35 Million | ▲ +334.8% |
| 2016 | 0.54x | CN¥22.96 Million | CN¥12.35 Million | ▼ -45.8% |
| 2015 | 0.99x | CN¥9.50 Million | CN¥9.43 Million | ▼ -77.4% |
| 2014 | 4.40x | CN¥3.20 Million | CN¥14.05 Million | ▲ +1130.7% |
| 2013 | 0.36x | CN¥3.89 Million | CN¥1.39 Million | — |